[耐药癌症新治疗策略的发展]。

Q4 Medicine Magyar onkologia Pub Date : 2021-06-03 Epub Date: 2021-05-09
Flóra Vajda, Eszter Bajtai, Balázs Gombos, Edina Karai, Lilla Hámori, Gergely Szakács, András Füredi
{"title":"[耐药癌症新治疗策略的发展]。","authors":"Flóra Vajda,&nbsp;Eszter Bajtai,&nbsp;Balázs Gombos,&nbsp;Edina Karai,&nbsp;Lilla Hámori,&nbsp;Gergely Szakács,&nbsp;András Füredi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>There are about 14 million new cancer cases and 8 million deaths every year. Every second man and one in every three women will get cancer during their lifetimes. Following decades of steady increase, death rates have stabilized due to increased awareness and prevention, early detection, and the emergence of more effective therapy. Yet despite all the advances cancer remains a major killer. Despite improved therapies, nearly all current treatments face the same problem: for many patients, they ultimately stop working. Therapy resistance is the ultimate challenge facing cancer researchers and patients today. In this review we present an overview of the most important resistance mechanisms, discussing progress in therapies designed to prevent or overcome anticancer therapy resistance. Finally, we present recent findings from our own laboratory on the development of new experimental models and new therapeutic approaches to combat multidrug resistant cancer.</p>","PeriodicalId":18175,"journal":{"name":"Magyar onkologia","volume":"65 2","pages":"176-187"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Development of novel treatment strategies for drug resistant cancer].\",\"authors\":\"Flóra Vajda,&nbsp;Eszter Bajtai,&nbsp;Balázs Gombos,&nbsp;Edina Karai,&nbsp;Lilla Hámori,&nbsp;Gergely Szakács,&nbsp;András Füredi\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>There are about 14 million new cancer cases and 8 million deaths every year. Every second man and one in every three women will get cancer during their lifetimes. Following decades of steady increase, death rates have stabilized due to increased awareness and prevention, early detection, and the emergence of more effective therapy. Yet despite all the advances cancer remains a major killer. Despite improved therapies, nearly all current treatments face the same problem: for many patients, they ultimately stop working. Therapy resistance is the ultimate challenge facing cancer researchers and patients today. In this review we present an overview of the most important resistance mechanisms, discussing progress in therapies designed to prevent or overcome anticancer therapy resistance. Finally, we present recent findings from our own laboratory on the development of new experimental models and new therapeutic approaches to combat multidrug resistant cancer.</p>\",\"PeriodicalId\":18175,\"journal\":{\"name\":\"Magyar onkologia\",\"volume\":\"65 2\",\"pages\":\"176-187\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Magyar onkologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/5/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magyar onkologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/5/9 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

每年大约有1400万新的癌症病例和800万人死亡。每两名男性和每三名女性中就有一名会在他们的一生中患上癌症。经过几十年的稳步增长,由于提高了认识和预防、早期发现以及出现了更有效的治疗方法,死亡率已经稳定下来。然而,尽管取得了这些进展,癌症仍然是一个主要杀手。尽管改进了治疗方法,但几乎所有现有的治疗方法都面临着同样的问题:对许多患者来说,它们最终会失效。治疗耐药性是当今癌症研究人员和患者面临的终极挑战。在这篇综述中,我们概述了最重要的耐药机制,讨论了旨在预防或克服抗癌治疗耐药的治疗进展。最后,我们介绍了我们自己的实验室在对抗多药耐药癌症的新实验模型和新治疗方法的发展方面的最新发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Development of novel treatment strategies for drug resistant cancer].

There are about 14 million new cancer cases and 8 million deaths every year. Every second man and one in every three women will get cancer during their lifetimes. Following decades of steady increase, death rates have stabilized due to increased awareness and prevention, early detection, and the emergence of more effective therapy. Yet despite all the advances cancer remains a major killer. Despite improved therapies, nearly all current treatments face the same problem: for many patients, they ultimately stop working. Therapy resistance is the ultimate challenge facing cancer researchers and patients today. In this review we present an overview of the most important resistance mechanisms, discussing progress in therapies designed to prevent or overcome anticancer therapy resistance. Finally, we present recent findings from our own laboratory on the development of new experimental models and new therapeutic approaches to combat multidrug resistant cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Magyar onkologia
Magyar onkologia Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
30
期刊最新文献
[The expanding possibilities of immuno-oncology treatments]. [Therapeutic drug monitoring for supporting oncological treatments: a new era begins]. [The role of classic serum tumor markers in the diagnosis and treatment monitoring of solid tumors in adults]. [Current therapeutic and familial implications of the genetic background of prostate cancer]. [Paraneoplastic endocrine syndromes: clinical picture and laboratory diagnostics].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1